Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03435211 · ClinicalTrials.gov registry record

Desaturation Validation of INVSENSOR00006

A clinical trial, sponsored by Masimo Corporation.

Completed
Registry status
52
Enrollment target

NCT03435211 is a clinical trial that has completed, run by Masimo Corporation. The registered enrollment target is 52 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03435211 has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
52 participants
Enrollment target

Study Summary

This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation compared to reference values obtained by a laboratory blood gas analyzer. Arterial blood samples will be collected from healthy adult subjects while undergoing a desaturation procedure wherein the concentration of oxygen inhaled is slowly reduced until the subject's arterial oxygen concentration is approximately 70%. The subject will then be returned to inhaling room air.

Interventions

  • DEVICE INVSENSOR00006

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2018-01-17
Est. Completion 2018-02-19

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT03435211

The ClinicalTrials.gov registry entry for NCT03435211 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00006 is the first listed.

NCT03435211 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03435211 about?

NCT03435211 is a clinical study titled "Desaturation Validation of INVSENSOR00006". This study is designed to compare the accuracy of a noninvasive measurement of oxygen saturation compared to reference values obtained by a laboratory blood gas analyzer. Arterial blood samples will be collected from healthy adult subjects while undergoing a desaturation procedure wherein the concen...

What is the current status of trial NCT03435211?

This trial is currently completed. The enrollment target is 52 participants. The study started on 2018-01-17. Estimated completion is 2018-02-19.

What interventions are being tested in trial NCT03435211?

The interventions under investigation include: INVSENSOR00006 (DEVICE).

Who is sponsoring clinical trial NCT03435211?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.